Pack Design For EU Orphan Drug Launch
Source: Almac Group
Almac was engaged by a virtual, US based Pharmaceutical client seeking EU commercial product approval for their first commercial product – an ultra-orphan, solid oral dose presentation. This EU launch project required designing both the primary and secondary packaging formats (blister / wallet) and origination of country-specific artwork to comply with individual EU market requirements.
        access the Case Study!
        
            Log In
        
    
    
    
    Get unlimited access to:
            Trend and Thought Leadership Articles
             
        
        
            Case Studies & White Papers
             
        
        
            Extensive Product Database
             
        
        
            Members-Only Premium Content
             
        
    
        Welcome Back! Please Log In to Continue.
        
            X
        
    
    Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.
        Subscribe to Pharmaceutical Online
        X
    
    
        Subscribe to Pharmaceutical Online
    
    